Clinical applications of reticulocyte hemoglobin indices, including reticulocyte hemoglobin equivalent (Ret-He) and reticulocyte hemoglobin content (CHr), among pregnant and postpartum women: A scoping review and evidence map
PLOS One · 13.11.2026 · 21 (11) · e0362481
DOI: 10.1371/journal.pone.0362481 ↗Kurz gefasst
Scoping Review in der Zeitschrift PLOS One, online erschienen am 13.11.2026. Verfasst von Miki Ohtsuki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Reticulocytes, Postpartum Period, Hemoglobins, Anemia, Iron-Deficiency. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early detection of iron deficiency during pregnancy and the postpartum period, a common condition associated with adverse maternal and neonatal outcomes, remains challenging with conventional iron markers. Reticulocyte hemoglobin indices, including reticulocyte hemoglobin equivalent and reticulocyte hemoglobin content, may enable earlier detection of iron-restricted erythropoiesis. We conducted a scoping review to map the clinical and research applications of these indices in pregnant and postpartum women. Following Joanna Briggs Institute methodology and PRISMA-ScR guidance, we searched PubMed, CENTRAL, Web of Science, and Ichushi Web for studies published from January 1, 1990, to May 31, 2025, and performed an updated search on April 21, 2026, for newly added or indexed records. Eligible studies involved pregnant women or women within 3 months postpartum in whom reticulocyte hemoglobin indices were evaluated for clinical or research purposes. We also constructed an evidence map to visualize the distribution of evidence and research gaps. Thirty-five studies were included. Evidence was most developed for diagnostic accuracy for iron deficiency and associations with iron-related biomarkers. Reticulocyte hemoglobin indices generally showed good diagnostic performance, although reported cut-off values varied widely across studies. Data from mid-to-late pregnancy remained limited. Studies using reticulocyte hemoglobin indices as indicators of response to iron therapy are increasing. Some studies examined longitudinal changes and reference values across pregnancy and the postpartum period; however, these studies were methodologically limited. Three studies examined associations between maternal reticulocyte hemoglobin indices and neonatal parameters, whereas no study evaluated maternal clinical outcomes. Overall, reticulocyte hemoglobin indices appear promising for assessing iron status and monitoring response to iron therapy in perinatal populations. However, substantial heterogeneity in study design, reference standards, and analytical platforms, together with limited longitudinal and outcome-oriented evidence, currently constrains broader clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.
- Department of Implementation Science in Public Health, Kyoto University School of Public Health, Kyoto, Japan.
ORCID-Profile: Miki Ohtsuki, Takuma Ohsuga, Yoshimitsu Takahashi
Zitieren
APA
Ohtsuki, M., Ohsuga, T., Ida, K., Tsuyuki, K., Egawa, M., Toyama, M., Takahashi, Y., Nakayama, T., & Mandai, M. (2026). Clinical applications of reticulocyte hemoglobin indices, including reticulocyte hemoglobin equivalent (Ret-He) and reticulocyte hemoglobin content (CHr), among pregnant and postpartum women: A scoping review and evidence map. PLOS One, 21(11), e0362481. https://doi.org/10.1371/journal.pone.0362481
Vancouver
Ohtsuki M, Ohsuga T, Ida K, Tsuyuki K, Egawa M, Toyama M, et al. Clinical applications of reticulocyte hemoglobin indices, including reticulocyte hemoglobin equivalent (Ret-He) and reticulocyte hemoglobin content (CHr), among pregnant and postpartum women: A scoping review and evidence map. PLOS One. 2026;21(11):e0362481. doi:10.1371/journal.pone.0362481
BibTeX
@article{Ohtsuki2026,
author = {Ohtsuki, Miki and Ohsuga, Takuma and Ida, Kohei and Tsuyuki, Kaori and Egawa, Miho and Toyama, Mayumi and Takahashi, Yoshimitsu and Nakayama, Takeo and Mandai, Masaki},
title = {Clinical applications of reticulocyte hemoglobin indices, including reticulocyte hemoglobin equivalent (Ret-He) and reticulocyte hemoglobin content (CHr), among pregnant and postpartum women: A scoping review and evidence map},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0362481},
doi = {10.1371/journal.pone.0362481}
}
EUVIMED